Pharmabiz

UK MHRA updates guidance for semaglutide prescribers and patients

UK MHRA updates guidance for semaglutide prescribers and patients: United Kingdom Saturday, February 7, 2026, 11:00 Hrs [IST] The Medicines and Healthcare products Regulatory Agen ...
Pharmabiz

Pfizer launches cost savings programme on TrumpRx lowering drug costs for millions of Americans

Pfizer launches cost savings programme on TrumpRx lowering drug costs for millions of Americans: New York Saturday, February 7, 2026, 10:00 Hrs [IST] Pfizer Inc. announced the lau ...
Pharmabiz

Industry optimistic US–India reciprocal tax cut from 50% to 18% to propel export prospects

Industry optimistic US–India reciprocal tax cut from 50% to 18% to propel export prospects: Nandita Vijayasimha, Bengaluru Saturday, February 7, 2026, 08:00 Hrs [IST] The pharma ...
Pharmabiz

GSK’s Nucala receives European Commission approval to treat chronic obstructive pulmonary disease

GSK’s Nucala receives European Commission approval to treat chronic obstructive pulmonary disease: London, UK Saturday, February 7, 2026, 09:00 Hrs [IST] GSK plc announced the E ...
Pharmabiz

National conference highlights future of integrative healthcare through 'Yoga Samyog'

The National Conference on Naturopathy–2026 concluded on February 6 in Delhi, marking a significant milestone in the advancement of evidence-based traditional medicine. Held on February 5 to 6, the ...
Pharmabiz

DoP issues separate guidelines for hiring of technical consultants and young professionals

DoP issues separate guidelines for hiring of technical consultants and young professionals: Gireesh Babu, New Delhi Saturday, February 7, 2026, 08:00 Hrs [IST] The Department of P ...
Pharmabiz

Pharma associations explore investment opportunities in UP as part of Pharma Conclave 1.0

Pharma associations explore investment opportunities in UP as part of Pharma Conclave 1.0 ...
Pharmabiz

DoP extends timeline for submission of applications under sub-scheme CFMDC

DoP extends timeline for submission of applications under sub-scheme CFMDC: Gireesh Babu, New Delhi Saturday, February 7, 2026, 08:00 Hrs [IST] The Department of Pharmaceuticals ( ...
Pharmabiz

Foresee Pharma gets fourth positive recommendation from DSMB to continue the Casppian Ph3 study, for central precocious puberty

Foresee Pharma gets fourth positive recommendation from DSMB to continue the Casppian Ph3 study, for central precocious puberty: Taipei Friday, February 6, 2026, 18:00 Hrs [IST] F ...
Pharmabiz

Jubilant Pharmova in Q3 clocks 17% income growth at Rs. 2,143 crore, PAT up by 17%

Jubilant Pharmova in Q3 clocks 17 per cent total income growth which is at Rs. 2,143 crore as against Rs. 1,831 crore in the corresponding quarter last year. Normalised PAT after adjusting for ...
Pharmabiz

Balt’s Squid liquid embolic receives US FDA approval for adjunctive treatment for chronic subdural hematomas

Balt’s Squid liquid embolic receives US FDA approval for adjunctive treatment for chronic subdural hematomas: Boston Friday, February 6, 2026, 17:00 Hrs [IST] Balt Inc, a global ...
Pharmabiz

Invivoscribe introduces LeukoStrat KMT2A + MRD Assay to advance high-sensitivity leukaemia testing in clinical trials and patient management worldwide

Invivoscribe introduces LeukoStrat KMT2A + MRD Assay to advance high-sensitivity leukaemia testing in clinical trials and patient management worldwide: San Diego Friday, February ...